Zobrazeno 1 - 10
of 47
pro vyhledávání: '"E.H. Moore"'
Autor:
Ahmad Massarweh, Michaël Bosco, Soria Iatmanen-Harbi, Clarice Tessier, Laura Amana, Patricia Busca, Isabelle Chantret, Christine Gravier-Pelletier, Stuart E.H. Moore
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 8, Pp 1477-1491 (2016)
We reported an oligosaccharide diphosphodolichol (DLO) diphosphatase (DLODP) that generates dolichyl-phosphate and oligosaccharyl phosphates (OSPs) from DLO in vitro. This enzyme could underlie cytoplasmic OSP generation and promote dolichyl-phosphat
Externí odkaz:
https://doaj.org/article/9a77360137a44117ae0fe955a561a1d6
Autor:
Ahmad Massarweh, Michaël Bosco, Soria Iatmanen-Harbi, Clarice Tessier, Nicolas Auberger, Patricia Busca, Isabelle Chantret, Christine Gravier-Pelletier, Stuart E.H. Moore
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 6, Pp 1029-1042 (2016)
Oligosaccharyl phosphates (OSPs) are hydrolyzed from oligosaccharide-diphosphodolichol (DLO) during protein N-glycosylation by an uncharacterized process. An OSP-generating activity has been reported in vitro, and here we asked if its biochemical cha
Externí odkaz:
https://doaj.org/article/b9d56dab62e34c5886594ebde4e64040
Autor:
Thierry Dupré, Julia Dancourt, Alain Couvineau, Elise Schaefer, Manuel Schiff, Nathalie Seta, Francesca Mattioli, Isabelle Chantret, Hélène Ogier de Baulny, Audrey Dupont, Pascale de Lonlay, Sandrine Vuillaumier-Barrot, Stuart E.H. Moore
Publikováno v:
Pediatric Research
Pediatric Research, 2019, 85 (3), pp.384-389. ⟨10.1038/s41390-018-0231-5⟩
Pediatric Research, 2019, 85 (3), pp.384-389. ⟨10.1038/s41390-018-0231-5⟩
BACKGROUND: Congenital disorders of glycosylation (CDG) includes ALG8 deficiency, a protein N-glycosylation defect with a broad clinical spectrum. If most of the 15 previously reported patients present an early-onset multisystem severe disease and ea
Autor:
Giusy Sala, Riccardo Ghidoni, Monica Thelestam, Stuart E.H. Moore, Christelle Durrant, Jana I. Fuehring, Agnès Rötig, Alexandra Willemetz, Abram Katz, D Chretien, Myriam Ermonval
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 6, p 2028 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2020, 21 (6), pp.2028. ⟨10.3390/ijms21062028⟩
Volume 21
Issue 6
International Journal of Molecular Sciences, MDPI, 2020, 21 (6), pp.2028. ⟨10.3390/ijms21062028⟩
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2020, 21 (6), pp.2028. ⟨10.3390/ijms21062028⟩
Volume 21
Issue 6
International Journal of Molecular Sciences, MDPI, 2020, 21 (6), pp.2028. ⟨10.3390/ijms21062028⟩
UDP-glucose (UDP-Glc) is synthesized by UGP2-encoded UDP-Glc pyrophosphorylase (UGP) and is required for glycoconjugate biosynthesis and galactose metabolism because it is a uridyl donor for galactose-1-P (Gal1P) uridyltransferase. Chinese hamster lu
Autor:
Clarice Tessier, Soria Iatmanen-Harbi, Patricia Busca, Stuart E.H. Moore, Laura Amana, Micha eumll Bosco, Christine Gravier-Pelletier, Ahmad Massarweh, Isabelle Chantret
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 8, Pp 1477-1491 (2016)
We reported an oligosaccharide diphosphodolichol (DLO) diphosphatase (DLODP) that generates dolichyl-phosphate and oligosaccharyl phosphates (OSPs) from DLO in vitro. This enzyme could underlie cytoplasmic OSP generation and promote dolichyl-phosphat
Autor:
Stuart E.H. Moore, Soria Iatmanen-Harbi, Michaël Bosco, Christine Gravier-Pelletier, Nicolas Auberger, Isabelle Chantret, Ahmad Massarweh, Patricia Busca, Clarice Tessier
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 6, Pp 1029-1042 (2016)
Journal of Lipid Research
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2016, 57 (6), pp.1029-1042. ⟨10.1194/jlr.M067330⟩
Journal of Lipid Research
Journal of Lipid Research, American Society for Biochemistry and Molecular Biology, 2016, 57 (6), pp.1029-1042. ⟨10.1194/jlr.M067330⟩
Oligosaccharyl phosphates (OSPs) are hydrolyzed from oligosaccharide-diphosphodolichol (DLO) during protein N-glycosylation by an uncharacterized process. An OSP-generating activity has been reported in vitro, and here we asked if its biochemical cha
Autor:
Lars Beedgen, Bianca Dimitrov, Gesche Düker, Matthias Zielonka, Michael J. Lentze, Catherine Barrey, Kai‐Christian Thiemann, Nathalie Seta, Rainer Ganschow, Stuart E.H. Moore, Verena Peters, Anna‐Marlen Hutter, Jonas Denecke, Irmgard Sinning, Georg F. Hoffmann, Christian Thiel, Sandrine Vuillaumier-Barrot, Thierry Dupré, Maximilian Breuer, Nastassja Himmelreich, Wolfgang Kölfen, Virginia Geiger, Andreas Hüllen, Andreas Ziegler
Publikováno v:
Human mutation. 40(7)
ALG3-CDG is one of the very rare types of congenital disorder of glycosylation (CDG) caused by variants in the ER-mannosyltransferase ALG3. Here, we summarize the clinical, biochemical, and genetic data of four new ALG3-CDG patients, who were identif
Publikováno v:
médecine/sciences. 30:47-54
The primary function of peptide N-glycanase (PNGase) is thought to be the deglycosylation of endoplasmic reticulum associated degradation (ERAD) substrates. However, inhibition of PNGase appears to have little effect upon the destruction rate of many
Autor:
Isabelle Chantret, Michaël Bosco, Ahmed Bouhss, Soria Iatmanen-Harbi, Ahmad Massarweh, Stuart E.H. Moore, Patricia Busca, Christine Gravier-Pelletier
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2017, 125, pp.952-964. ⟨10.1016/j.ejmech.2016.10.013⟩
European Journal of Medicinal Chemistry, 2017, 125, pp.952-964. ⟨10.1016/j.ejmech.2016.10.013⟩
European Journal of Medicinal Chemistry, Elsevier, 2017, 125, pp.952-964. 〈10.1016/j.ejmech.2016.10.013〉
European Journal of Medicinal Chemistry, Elsevier, 2017, 125, pp.952-964. ⟨10.1016/j.ejmech.2016.10.013⟩
European Journal of Medicinal Chemistry, 2017, 125, pp.952-964. ⟨10.1016/j.ejmech.2016.10.013⟩
European Journal of Medicinal Chemistry, Elsevier, 2017, 125, pp.952-964. 〈10.1016/j.ejmech.2016.10.013〉
International audience; Citronellyl- and solanesyl-based dolichol linked oligosaccharide (DLO) analogs were synthesized and tested along with undecaprenyl compounds for their ability to inhibit the release of [(3)H]OSP from [(3)H]DLO by mammalian liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996e7812355f2e594d2162ba65b8c864
https://hal.archives-ouvertes.fr/hal-01440749
https://hal.archives-ouvertes.fr/hal-01440749
Autor:
E. Mintet, S. Sabry, Nathalie Seta, Vassili Valayannopoulos, N. Dorison, Thierry Dupré, Delphine Héron, Cyril Mignot, Isabelle Chantret, Stuart E.H. Moore, M. Fasseu, Sandrine Vuillaumier-Barrot
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 11 (1), pp.84. ⟨10.1186/s13023-016-0468-1⟩
Orphanet Journal of Rare Diseases, 2016, 11 (1), pp.84. ⟨10.1186/s13023-016-0468-1⟩
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 11 (1), pp.84. ⟨10.1186/s13023-016-0468-1⟩
Orphanet Journal of Rare Diseases, 2016, 11 (1), pp.84. ⟨10.1186/s13023-016-0468-1⟩
Background Type I congenital disorders of glycosylation (CDG-I) are mostly complex multisystemic diseases associated with hypoglycosylated serum glycoproteins. A subgroup harbour mutations in genes necessary for the biosynthesis of the dolichol-linke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5834837e5385f701f2f954e2b9f8b3
https://www.hal.inserm.fr/inserm-01336846
https://www.hal.inserm.fr/inserm-01336846